A detailed history of Us Bancorp \De\ transactions in Danaher Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 508,771 shares of DHR stock, worth $117 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
508,771
Previous 505,380 0.67%
Holding current value
$117 Million
Previous $126 Million 12.01%
% of portfolio
0.18%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$239.25 - $280.76 $811,296 - $952,057
3,391 Added 0.67%
508,771 $141 Million
Q2 2024

Aug 06, 2024

SELL
$235.51 - $267.98 $560,278 - $637,524
-2,379 Reduced 0.47%
505,380 $126 Million
Q1 2024

May 07, 2024

BUY
$224.58 - $256.19 $2.66 Million - $3.03 Million
11,832 Added 2.39%
507,759 $127 Million
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $12.4 Million - $15.7 Million
67,240 Added 15.69%
495,927 $115 Million
Q3 2023

Nov 03, 2023

BUY
$233.08 - $265.59 $5.99 Million - $6.83 Million
25,709 Added 6.38%
428,687 $106 Million
Q2 2023

Aug 09, 2023

BUY
$224.99 - $256.14 $12.5 Million - $14.2 Million
55,539 Added 15.99%
402,978 $96.7 Million
Q1 2023

May 09, 2023

BUY
$239.75 - $277.0 $5.51 Million - $6.36 Million
22,967 Added 7.08%
347,439 $87.6 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $29.5 Million - $34.5 Million
122,289 Added 60.48%
324,472 $86.1 Million
Q3 2022

Oct 27, 2022

SELL
$247.06 - $1507.4 $1.06 Million - $6.5 Million
-4,310 Reduced 2.09%
202,183 $52.2 Million
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $273,387 - $345,507
-1,153 Reduced 0.56%
206,493 $52.4 Million
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $701,318 - $860,761
-2,726 Reduced 1.3%
207,646 $60.9 Million
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $666,526 - $750,800
-2,282 Reduced 1.07%
210,372 $69.2 Million
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $600,223 - $733,008
-2,205 Reduced 1.03%
212,654 $64.7 Million
Q2 2021

Aug 05, 2021

SELL
$225.08 - $271.69 $1.36 Million - $1.64 Million
-6,026 Reduced 2.73%
214,859 $57.7 Million
Q1 2021

Apr 28, 2021

SELL
$212.38 - $245.9 $602,734 - $697,864
-2,838 Reduced 1.27%
220,885 $49.7 Million
Q4 2020

Feb 04, 2021

SELL
$212.5 - $245.46 $1.43 Million - $1.66 Million
-6,748 Reduced 2.93%
223,723 $49.7 Million
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $591,891 - $719,417
-3,341 Reduced 1.43%
230,471 $49.6 Million
Q2 2020

Aug 07, 2020

SELL
$128.7 - $176.83 $65,508 - $90,006
-509 Reduced 0.22%
233,812 $41.3 Million
Q1 2020

May 13, 2020

SELL
$121.39 - $169.05 $371,089 - $516,785
-3,057 Reduced 1.29%
234,321 $32.4 Million
Q4 2019

Feb 04, 2020

SELL
$133.47 - $153.48 $254,660 - $292,839
-1,908 Reduced 0.8%
237,378 $36.4 Million
Q3 2019

Nov 08, 2019

SELL
$135.4 - $146.47 $449,934 - $486,719
-3,323 Reduced 1.37%
239,286 $34.6 Million
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $255,004 - $293,496
-2,042 Reduced 0.83%
242,609 $34.7 Million
Q1 2019

May 08, 2019

SELL
$97.62 - $132.29 $420,156 - $569,376
-4,304 Reduced 1.73%
244,651 $32.3 Million
Q4 2018

Feb 13, 2019

BUY
$94.85 - $109.54 $780,994 - $901,952
8,234 Added 3.42%
248,955 $25.7 Million
Q3 2018

Nov 01, 2018

SELL
$98.13 - $108.9 $643,929 - $714,601
-6,562 Reduced 2.65%
240,721 $26.2 Million
Q2 2018

Aug 08, 2018

SELL
$96.1 - $103.24 $105,806 - $113,667
-1,101 Reduced 0.44%
247,283 $24.4 Million
Q1 2018

May 08, 2018

SELL
$92.16 - $103.8 $276,940 - $311,919
-3,005 Reduced 1.2%
248,384 $24.3 Million
Q4 2017

Feb 02, 2018

BUY
$85.26 - $94.62 $95,746 - $106,258
1,123 Added 0.45%
251,389 $23.3 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $19.8 Million - $22.1 Million
250,266
250,266 $21.5 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.